Control of keratinocyte differentaiation by integrins

Project Information

CAMPBELLDOUGLAS

Grant agreement ID: QLG1-CT-1999-51256

Project closed

Start date 1 January 2000

End date 31 December 2001

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 113 872,00

EU contribution € 113 872,00

Coordinated by

Imperial Cancer Research Fund
United Kingdom

Objective

Extracellular matrix receptors of the B1 integrin family regulate terminal differentiation of normal keratinocytes and are frequently mis-expressed in tumors. The aim of this proposal is to investigate the signalling pathways by which integrins control differentiation.

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

Imperial Cancer Research Fund

• EU contribution: No data
• Address: Lincoln's Inn Fields 44 ; WC2A 3PX LONDON ; United Kingdom
• Total cost: No data